3 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Nicolaus Radford of Nauticus Robotics, Josh Teekell of SmartAC.com, and Zhifeng Ren of the Texas Center for Superconductivity at UH. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from robotics to superconductivity — recently making headlines in Houston innovation.

Nicolaus Radford, founder and CEO of Nauticus Robotics

Houston-based Nauticus Robotics founder, Nicolaus Radford, shares the latest from his company and why we're primed for a hardtech movement. Image via LinkedIn

It's been a busy past year or so for Nicolaus Radford, founder and CEO of Nauticus Robotics. He's taken his company public at a difficult time for the market, launched new partnerships with the United States Marine Corps, and even welcomed a new family member.

Originally founded in 2014 as Houston Mechatronics, Nauticus Robotics has designed a fleet of underwater robots and a software platform for autonomous operations. Radford caught up with InnovationMap about these recent milestones for him and the company in an interview.

"I look back on it and it's, you know, ringing the Nasdaq bell when we listed, and giving that speech at the podium — it was a surreal moment," he tells InnovationMap. "I was excited but cautious at the same time. I mean, the life of a CEO of a public company at large, it's all about the process following a process, the regulations, the administration of the public company, the filings, the reportings — it can feel daunting. I have to rise to the occasion to tackle that in this the next stage of the company." Read more.

​Josh Teekell, founder and CEO of SmartAC.com

Josh Teekell joins the Houston Innovators Podcast to discuss the latest from his company, which just closed its series B. Photo courtesy

A Houston startup that combines unique sensor technology with software analysis has raised its next round of funding to — according to Founder and CEO Josh Teekell — turbocharge its sales.

SmartAC.com's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. Teekell says he's focused on sales, and he's going to do that with the $22 million raised in the series B round that closed this month. He says the company will also grow its team that goes out to deploy the technology and train the contractors on the platform.

"This funding really buys us a couple years of runway through the end of next year and allows us to focus on getting to cash flow breakeven, which is right around our wheelhouse of our abilities here in the next 12 months," Teekell says. "In general, we've accomplished everything we'd be able to accomplish on the hardware side, and now it's just about deployment." Read more.

Zhifeng Ren, director of the Texas Center for Superconductivity at UH

A team of researchers out of the Texas Center for Superconductivity at the University of Houston has discovered a faster way of transportation. Photo via UH.edu

Researchers at the University of Houston and in Germany released a proof-of-concept paper this month that uncovers a new, fuel efficient means of transportation that they say could one day make air travel and traditional freight transport obsolete.

"I call it a world-changing technology,” Zhifeng Ren, director of the Texas Center for Superconductivity at UH and author of the paper, said in a statement.

Published in the journal APL Energy, the paper demonstrates a new way of using superconductors to move vehicles along existing highways while transporting liquified hydrogen at the same time. Until now, the costs of using superconductivity for transportation has held back innovation in the field. This model also reduces the need for a separate specialized pipeline system to transport liquified hydrogen that's able to keep the fuel source at minus 424 degrees Fahrenheit. Read more.

From Your Site Articles
A team of researchers out of the Texas Center for Superconductivity at the University of Houston has discovered a faster way of transportation. Photo via UH.edu

Houston researchers identify new tech for unprecedented transportation speeds

zoom, zoom

Researchers at the University of Houston and in Germany released a proof-of-concept paper this month that uncovers a new, fuel efficient means of transportation that they say could one day make air travel and traditional freight transport obsolete.

"I call it a world-changing technology,” Zhifeng Ren, director of the Texas Center for Superconductivity at UH and author of the paper, said in a statement.

Published in the journal APL Energy, the paper demonstrates a new way of using superconductors to move vehicles along existing highways while transporting liquified hydrogen at the same time. Until now, the costs of using superconductivity for transportation has held back innovation in the field. This model also reduces the need for a separate specialized pipeline system to transport liquified hydrogen that's able to keep the fuel source at minus 424 degrees Fahrenheit.

The model uses a similar concept to what's behind already existing magnetically levitating trains that operate on a magnetized rail, with superconductors embedded in the train's undercarriage. In Ren's model, superconductors would be embedded into existing highway infrastructure and magnets added to the undercarriages of vehicles. Liquified hydrogen would be used to cool the superconductor highway as vehicles move across it.

The idea could apply to trains, cargo trucks, and even personal cars, according to the paper. Better yet, the vehicles could travel up to 400 mph while on the highway. Drivers would then use the vehicle's traditional or electric motor once they exit.

"Instead of 75 mph, you could go 400 mph, from Houston to Los Angeles, or Houston to New York in just a few hours," Ren said in a statement.

Ren adds that this method would also require drivers to consume less fuel or power, cutting down on cost and environmental impact.

Technical and economic details still need to be addressed. But Ren believes "the project’s potential long-term economic and environmental benefits, would outweigh the upfront costs," according to a statement.

The paper joins a number of other innovative concepts coming out of UH in recent months. Recently, a research team at the university upgraded at-home rapid COVID-19 testing to make results more detectable via glow-in-the-dark materials.

Late last year the university also opened its

new tech transfer facility, and early this year it signed an agreement with India to bring a data center focused on energy to campus.


cropfilter_vintageloyaltyshopping_cartlocal_librarydeleteThe illustration shows the theorized superconducting highway for energy transport and storage and superconductor levitation. Image via UH.edu

UH has found a way to instantly zap COVID-10. Andriy Onufriyenko/Getty Images

University of Houston designs device that instantly kills COVID-19

ZAPPING COVID-19

While the world rushes to find a COVID-19 vaccine, scientists from the University of Houston have found a way to trap and kill the virus — instantly.

The team has designed a "catch and kill" air filter that can nullify the virus responsible for COVID-19. Researchers reported that tests at the Galveston National Laboratory found 99.8 percent of the novel SARS-CoV-2 — which causes COVID-19 — was killed in a single pass through the filter.

Zhifeng Ren, director of the Texas Center for Superconductivity at UH, collaborated with Monzer Hourani, CEO of Medistar, a Houston-based medical real estate development firm, plus other researchers to design the filter, which is described in a paper published in Materials Today Physics.

Researchers were aware the virus can remain in the air for about three hours, which required a filter that could quickly remove it. The added pressure of businesses reopening created an urgency in controlling the spread of the virus in air conditioned spaces, according to UH.

Meanwhile, to scorch the virus — which can't survive above around 158 degrees Fahrenheit — researchers instilled a heated filter. By blasting the temperature to around 392 F, they were able to kill the virus almost instantly.

The filter also killed 99.9 percent of the anthrax spores, according to researchers.

A prototype was built by a local workshop and first tested at Ren's lab for the relationship between voltage/current and temperature; it then went to the Galveston lab to be tested for its ability to kill the virus. Ren says it satisfies the requirements for conventional heating, ventilation and air conditioning (HVAC) systems.

"This filter could be useful in airports and in airplanes, in office buildings, schools and cruise ships to stop the spread of COVID-19," said Ren, MD Anderson Chair Professor of Physics at UH and co-corresponding author for the paper, in a statement. "Its ability to help control the spread of the virus could be very useful for society."

Medistar executives are also proposing a desk-top model, capable of purifying the air in an office worker's immediate surroundings, Ren added.

Developers have called for a phased roll-out of the device, with a priority on "high-priority venues, where essential workers are at elevated risk of exposure — particularly schools, hospitals and health care facilities, as well as public transit environs such as airplanes."

The hope, developers add, is that the filter will protect frontline workers in essential industries and allow nonessential workers to return to public work spaces.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

Alzheimer’s research

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March.

Dr. Ryan S. Dhindsa is an assistant professor of pathology & immunology at Baylor and a principal investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI). He hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation.

“It is an honor to receive this support from the Cure One, Cure Many Award. Viral infections are emerging as a major, underappreciated driver of Alzheimer's disease, and this award will allow our team to conduct the most comprehensive screen of viral exposures and host genetics in Alzheimer's to date, spanning over a million individuals,” Dhindsa said in a news release. “Our goal is to identify which viruses matter most, why some people are more vulnerable than others, and ultimately move the field closer to new therapeutic strategies for patients.”

Roughly 150 million people worldwide will suffer from Alzheimer’s by 2050, making it the most common cause of dementia in the world. Despite this, scientists are still at a loss as to what exactly causes it.

Dhindsa’s research is part of a new range of theories that certain viral infections may trigger Alzheimer’s. His team will take a two-fold approach. First, they will analyze the medical records of more than a million individuals looking for patterns. Second, they will analyze viral DNA in stem cell-derived brain cells to see how the infections could contribute to neurological decay. The scale of the genomic data gathering is unprecedented and may highlight a link that traditional studies have missed.

Also joining the project are Dr. Caleb Lareau of Memorial Sloan Kettering Cancer Center and Dr. Artem Babaian of the University of Toronto. Should a link be found, it would open the door to using anti-virals to prevent or treat Alzheimer’s.

View All Listings